The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1225
January 2, 2006
View Complete Issue         Table of Contents 2019 
Statins for High-Risk Patients without Heart Disease or High Cholesterol
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Statins for High-Risk Patients without Heart Disease or High Cholesterol
January 2, 2006 (Issue: 1225)
The FDA recently approved the use of atorvastatin (Lipitor) to reduce the risk of heart attack and stroke in patients without heart disease who have type 2 diabetes plus other risk factors, with or without hypercholesterolemia. The agency also...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Statins for High-Risk Patients without Heart Disease or High Cholesterol
Article code: 1225a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.